Institute of Cancer Sciences celebrates International Clinical Trials Day
The Institute of Cancer Sciences held a symposium on 18th May 2018 at The Hilton Grosvenor Hotel, Glasgow to celebrate International Clinical Trials Day. More than 70 delegates from healthcare, clinical trials regulatory affairs, patient and consumers involvement, and laboratory research attended.
The theme was “Precision Medicine as applied to Oncology” and featured presentations from Dr David Vetrie on exciting developments in the research and management of Chronic Myeloid Leukaemia led by Glasgow, and Professor Jeff Evans, on the pre-clinical and clinical development of novel agents in solid tumours with a particular emphasis on pancreatic cancer.
Dr Fiona Thomson highlighted the critical role of biomarkers in precision oncology studies; Dr Audrey Morrison discussed the ethical and regulatory challenges in precision oncology clinical trials; and Dr Kathe Robb, from the Institute of Health and Wellbeing, discussed how health behaviours can influence participation with a particular focus on cancer prevention programmes.
First published: 26 June 2018